Leadership Overview
Biocon has 7 executives leading key functions including strategy, finance, operations, technology, and human resources.
Driven by a mission to provide equitable access to life-saving healthcare, Biocon is dedicated to developing and manufacturing high-quality, affordable medicines for chronic conditions, impacting over 120 countries.
Driven by a mission to provide equitable access to life-saving healthcare, Biocon is dedicated to developing and manufacturing high-quality, affordable medicines for chronic conditions, impacting over 120 countries.
Leadership Roles at Biocon
Lillian Ramos - Chief Executive Officer
Lillian Ramos, the Chief Executive Officer at Biocon, directs the overarching corporate strategy and global market positioning. Overseeing all business units, Ramos ensures alignment with Biocon's mission of providing affordable healthcare solutions worldwide. This leadership role involves driving innovation in biopharmaceutical development and manufacturing, focusing on chronic conditions like diabetes and oncology. By optimizing resource allocation and fostering cross-functional collaboration, Lillian Ramos directly impacts the company's ability to expand its reach across 120+ countries. Ultimately, Ramos secures Biocon's competitive edge in the global biopharma landscape, emphasizing sustainable growth and equitable access to essential medicines.
Revathi Sakamuri - Principal Chief Executive Officer
Revathi Sakamuri, the Principal Chief Executive Officer at Biocon, spearheads critical strategic initiatives and operational excellence across the organization. Sakamuri's leadership ensures the seamless integration of Biocon's diverse business units, including Generics, Biosimilars, Novel Biologics, and Research Services. This executive function involves cultivating strategic partnerships and driving market penetration in key therapeutic areas such as immunology and diabetes. By championing advanced research and development pipelines, Revathi Sakamuri directly contributes to Biocon's position as a global leader in biosimilar insulins and monoclonal antibodies. The focus remains on enhancing patient access to life-saving treatments and reinforcing Biocon's commitment to global health equity.
Shreehas Tambe - Chief Executive Officer & Managing Director
Shreehas Tambe, the Chief Executive Officer & Managing Director at Biocon, executes the company's strategic vision and operational management. Tambe's dual role encompasses driving growth across all business segments, including Generics, Biosimilars, Novel Biologics, and Research Services. This leadership position involves overseeing the development and manufacturing of high-quality, affordable medicines for chronic conditions, ensuring Biocon's global competitiveness. By fostering a culture of innovation and operational efficiency, Shreehas Tambe directly supports Biocon's expansion into over 120 countries. The objective is to solidify Biocon's standing as a fully integrated global biopharma leader and advance the mission of equitable healthcare access.
Kedar Upadhye - Chief Financial Officer
Kedar Upadhye, the Chief Financial Officer at Biocon, manages the company's financial health and strategic investment planning. Upadhye oversees all financial operations, including budgeting, forecasting, and capital allocation, ensuring robust fiscal management across Biocon's global operations. This critical function involves optimizing financial performance to support the development and manufacturing of affordable medicines for chronic conditions. By driving financial discipline and exploring strategic funding opportunities, Kedar Upadhye directly enables Biocon's expansion into new markets and therapeutic areas. The focus remains on sustaining profitability while advancing the mission of equitable access to life-saving healthcare solutions worldwide.
Arun Gupta - Chief Operating Officer
Arun Gupta, the Chief Operating Officer at Biocon, directs the company's global manufacturing and supply chain operations. Gupta oversees the efficient production of high-quality, affordable medicines, ensuring compliance with stringent regulatory standards across all facilities. This operational leadership role involves optimizing production processes for generics, biosimilars, and novel biologics, thereby enhancing Biocon's capacity to serve patients in over 120 countries. By driving operational efficiencies and implementing best practices in manufacturing, Arun Gupta directly contributes to Biocon's mission of providing equitable access to critical healthcare solutions. The emphasis is on maintaining product integrity and ensuring reliable delivery of essential treatments.
Mandar Ghatnekar - Chief Technology Officer
Mandar Ghatnekar, the Chief Technology Officer at Biocon, leads the company's technological innovation and digital transformation initiatives. Ghatnekar oversees the integration of advanced technologies across research, development, and manufacturing processes, ensuring Biocon remains at the forefront of biopharmaceutical innovation. This executive role involves enhancing data analytics capabilities and cybersecurity measures to protect sensitive information and streamline operations. By championing cutting-edge technological solutions, Mandar Ghatnekar directly supports the development of novel biologics and biosimilars, contributing to Biocon's mission of providing affordable healthcare. The focus is on leveraging technology to accelerate drug discovery and improve patient outcomes globally.
Naveen Narayanan - Chief Human Resources Officer
Naveen Narayanan, the Chief Human Resources Officer at Biocon, shapes the company's talent strategy and cultivates a high-performance organizational culture. Narayanan oversees all human resources functions, including talent acquisition, employee development, and compensation, ensuring Biocon attracts and retains top talent globally. This leadership position involves fostering an inclusive work environment that supports Biocon's mission of equitable access to healthcare. By implementing robust HR policies and programs, Naveen Narayanan directly contributes to employee engagement and organizational effectiveness across Biocon's diverse business units. The objective is to build a skilled and motivated workforce capable of driving innovation and achieving strategic business goals.
Explore Leadership Teams in Manufacturing
Sarepta Therapeutics, Inc. is a global commercial-stage biopharmaceutical company founded in 1980 and headquartered in Cambridge, Massachusetts. The company is focused on the discovery, development, and commercialization of precision genetic medicines for rare diseases, with particular leadership in Duchenne muscular dystrophy and limb-girdle muscular dystrophies. Sarepta's multi-platform Precision Genetic Medicine Engine spans gene therapy, RNA-targeted therapeutics, and gene editing modalities. The company holds multiple FDA-approved treatments and maintains a broad pipeline of programs across neuromuscular and central nervous system disorders. Sarepta operates globally with locations across North America, Europe, and Asia, and trades on the NASDAQ under the ticker symbol SRPT.
Company Leadership AN
FQ
KM
BF
Gufic Group is a respected player in the pharmaceutical industry, established in 1970, known for its innovative and high-quality pharmaceutical and herbal products, along with a diverse range of APIs. They are recognized as one of India's largest manufacturers of lyophilized injections, offering a variety of products including antibiotics, antifungals, and antiviral treatments. Their extensive network facilitates the supply of these products to major hospital chains and leading medical facilities across India. Gufic is committed to research and development, continuously launching advanced new products while expanding their international footprint.
Company Leadership DR
RK
NY
SD
At Simtra, the company is dedicated to developing and manufacturing quality sterile injectable products to meet evolving patient needs. The company works with precision and transparency, setting high standards and paying attention to every detail, in order to ensure that the company makes your product right the first time, deliver it on time and meet your requirements in full. The company is made for this, with the company's extensive slate of services and product delivery options.
Company Leadership
TD
RG
Genomma Lab Internacional is a leading provider of innovative health and personal care products aimed at enhancing health and well-being. The company offers a wide range of solutions for various health issues, including hydration, pain relief, and skincare. Its intended clients include individuals seeking effective and safe products to improve their quality of life. Genomma Lab is committed to sustainability and positively impacting communities while ensuring the satisfaction of its shareholders.
Company Leadership RA
GC
AG
MG
Frequently Asked Questions Regarding Biocon Top Executives and Leadership Team
